These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16432664)

  • 1. Differential expression of HER-2/NEU receptor of invasive mammary carcinoma between Caucasian and African American patients in the Detroit metropolitan area. Correlation with overall survival and other prognostic factors.
    Al-Abbadi MA; Washington TA; Saleh HA; Tekyi-Mensah SE; Lucas DR; Briston CA
    Breast Cancer Res Treat; 2006 May; 97(1):3-8. PubMed ID: 16432664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer.
    Spizzo G; Obrist P; Ensinger C; Theurl I; Dünser M; Ramoni A; Gunsilius E; Eibl G; Mikuz G; Gastl G
    Int J Cancer; 2002 Apr; 98(6):883-8. PubMed ID: 11948467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.
    Azizun-Nisa ; Bhurgri Y; Raza F; Kayani N
    Asian Pac J Cancer Prev; 2008; 9(4):553-6. PubMed ID: 19256737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.
    Ihemelandu CU; Leffall LD; Dewitty RL; Naab TJ; Mezghebe HM; Makambi KH; Adams-Campbell L; Frederick WA
    J Surg Res; 2007 Nov; 143(1):109-18. PubMed ID: 17950079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of plasma HER-2/neu in African American and Hispanic women with breast cancer.
    Wu Y; Khan H; Chillar R; Vadgama JV
    Int J Oncol; 1999 Jun; 14(6):1021-37. PubMed ID: 10339653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Race modifies the association between breast carcinoma pathologic prognostic indicators and the positive status for HER-2/neu.
    Stark AT; Claud S; Kapke A; Lu M; Linden M; Griggs J
    Cancer; 2005 Nov; 104(10):2189-96. PubMed ID: 16208704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine assessment of hormonal receptor and her-2/neu status underscores the need for more therapeutic targets in Kenyan women with breast cancer.
    Nyagol J; Nyong'o A; Byakika B; Muchiri L; Cocco M; de Santi MM; Spina D; Bellan C; Lazzi S; Kostopoulos I; Luzi P; Leoncini L
    Anal Quant Cytol Histol; 2006 Apr; 28(2):97-103. PubMed ID: 16637512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological characteristics of triple-negative invasive mammary carcinomas in African-American versus Caucasian women.
    Tawfik O; Davis K; Kimler BF; Davis MK; Hull S; Fan F; Khan QJ; O'Dea AP; Thomas P
    Ann Clin Lab Sci; 2010; 40(4):315-23. PubMed ID: 20947804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-erbB-2 protein level in tissue and sera of breast cancer patients: a possibly useful clinical correlation.
    Quaranta M; Daniele A; Coviello M; Savonarola A; Abbate I; Venneri MT; Paradiso A; Stea B; Zito A; Labriola A; Schittulli F
    Tumori; 2006; 92(4):311-7. PubMed ID: 17036522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survival.
    Oprea-Ilies G; Haus E; Sackett-Lundeen L; Liu Y; McLendon L; Busch R; Adams A; Cohen C
    Breast Cancer Res Treat; 2013 Feb; 137(3):677-87. PubMed ID: 23250547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Her-2/neu extracellular domain in breast cancer patients-correlation with prognosis and clinicopathological parameters including steroid receptor, Her-2/neu receptor coexpression.
    Barić M; Kulić A; Sirotković-Skerlev M; Dedić Plavetić N; Vidović M; Horvatić-Herceg G; Vrbanec D
    Pathol Oncol Res; 2015 Jul; 21(3):589-95. PubMed ID: 25367073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of HER-2/neu and survival of breast cancer patients attending a specialized breast clinic in Kolkata, Eastern India.
    Jana D; Mandal S; Mukhopadhyay M; Mitra D; Mukhopadhyay SK; Sarkar DK
    Asian Pac J Cancer Prev; 2012; 13(8):3851-5. PubMed ID: 23098482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics.
    Jones BA; Kasl SV; Howe CL; Lachman M; Dubrow R; Curnen MM; Soler-Vila H; Beeghly A; Duan F; Owens P
    Cancer; 2004 Sep; 101(6):1293-301. PubMed ID: 15368321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 as a marker of prognosis in African-American women with breast cancer.
    Dookeran KA; Dignam JJ; Ferrer K; Sekosan M; McCaskill-Stevens W; Gehlert S
    Ann Surg Oncol; 2010 May; 17(5):1398-405. PubMed ID: 20049641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race and the prognostic influence of p53 in women with breast cancer.
    Dookeran KA; Dignam JJ; Holloway N; Ferrer K; Sekosan M; McCaskill-Stevens W; Gehlert S
    Ann Surg Oncol; 2012 Jul; 19(7):2334-44. PubMed ID: 22434242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER-2/neu expression as a predictor of response to neoadjuvant docetaxel in patients with operable breast carcinoma.
    Learn PA; Yeh IT; McNutt M; Chisholm GB; Pollock BH; Rousseau DL; Sharkey FE; Cruz AB; Kahlenberg MS
    Cancer; 2005 Jun; 103(11):2252-60. PubMed ID: 15834928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.
    Sharif MA; Mamoon N; Mushtaq S; Khadim MT
    J Coll Physicians Surg Pak; 2009 Feb; 19(2):99-103. PubMed ID: 19208313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive factors and subtypes of breast cancer defined by estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2: a register-based study from Korea.
    Lee JS; Oh M; ;
    Clin Breast Cancer; 2014 Dec; 14(6):426-34. PubMed ID: 25034438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities and survival among breast cancer patients.
    Field TS; Buist DS; Doubeni C; Enger S; Fouayzi H; Hart G; Korner EJ; Lamerato L; Bachman DJ; Ellis J; Herrinton L; Hornbrook MC; Krajenta R; Liu L; Yao J
    J Natl Cancer Inst Monogr; 2005; (35):88-95. PubMed ID: 16287892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.